AOAlessandro Onori

Alessandro Onori

*This is an algorithmically generated author record based on publicly available information.

Alessandro Onori has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Davide Bellini

    “Sapienza” University of Rome

    2 shared publications
  • Iacopo Carbone

    Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, 00185 Rome, Italy

    2 shared publications
  • Marco Rengo

    Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy

    2 shared publications
  • Simone Vicini

    Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome–Academic Diagnostic Imaging Division, I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy

    2 shared publications
  • Andrea Laghi

    Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Department of Diagnostic Imaging, via Manzoni 56, 20089 Rozzano, Milan, Italy; Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands

    1 shared publication
  • Antonella Bordin

    Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy

    1 shared publication

Latest Publications

  • Clinical Cases

    by Federica Giulio, Elena Orlando, Alessandro Onori, Simone Ciaglia, Bianca Rocco, Pier Giorgio Nardis, Davide Curione, Nunzia Di Meo, Teresa Falcone

  • Open Access

    Development and Validation of Artificial-Intelligence-Based Radiomics Model Using Computed Tomography Features for Preoperative Risk Stratification of Gastrointestinal Stromal Tumors

    by Marco Rengo, Alessandro Onori, Damiano Caruso, Davide Bellini, Francesco Carbonetti, Domenico De Santis, Simone Vicini, Marta Zerunian, Elsa Iannicelli, Iacopo Carbone, et al.

    Background: preoperative risk assessment of gastrointestinal stromal tumors (GISTS) is required for optimal and personalized treatment planning. Radiomics features are promising tools to predict risk assessment. The purpose of this study is to develop and validate an artificial intelligence classification algorithm, based on CT features, to define GIST’s prognosis as determined by the Miettinen classification. Methods: patients with histological diagnosis of GIST and CT studies were retrospectively enrolled. Eight morphologic and 30 texture CT features were extracted from each tumor and combined to obtain three models (morphologic, texture and combined). Data were analyzed using a machine learning classification (WEKA). For each classification process, sensitivity, specificity, accuracy and area under the curve were evaluated. Inter- and intra-reader agreement were also calculated. Results: 52 patients were evaluated. In the validation population, highest performances were obtained by the combined model (SE 85.7%, SP 90.9%, ACC 88.8%, and AUC 0.954) followed by the morphologic (SE 66.6%, SP 81.8%, ACC 76.4%, and AUC 0.742) and texture (SE 50%, SP 72.7%, ACC 64.7%, and AUC 0.613) models. Reproducibility was high of all manual evaluations. Conclusions: the AI-based radiomics model using a CT feature demonstrates good predictive performance for preoperative risk stratification of GISTs.


  • Open Access

    A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer

    by Davide Bellini, Marika Milan, Antonella Bordin, Roberto Rizzi, Marco Rengo, Simone Vicini, Alessandro Onori, Iacopo Carbone, Elena De Falco

    Radiological imaging is currently employed as the most effective technique for screening, diagnosis, and follow up of patients with breast cancer (BC), the most common type of tumor in women worldwide. However, the introduction of the omics sciences such as metabolomics, proteomics, and molecular genomics, have optimized the therapeutic path for patients and implementing novel information parallel to the mutational asset targetable by specific clinical treatments. Parallel to the “omics” clusters, radiological imaging has been gradually employed to generate a specific omics cluster termed “radiomics”. Radiomics is a novel advanced approach to imaging, extracting quantitative, and ideally, reproducible data from radiological images using sophisticated mathematical analysis, including disease-specific patterns, that could not be detected by the human eye. Along with radiomics, radiogenomics, defined as the integration of “radiology” and “genomics”, is an emerging field exploring the relationship between specific features extracted from radiological images and genetic or molecular traits of a particular disease to construct adequate predictive models. Accordingly, radiological characteristics of the tissue are supposed to mimic a defined genotype and phenotype and to better explore the heterogeneity and the dynamic evolution of the tumor over the time. Despite such improvements, we are still far from achieving approved and standardized protocols in clinical practice. Nevertheless, what can we learn by this emerging multidisciplinary clinical approach? This minireview provides a focused overview on the significance of radiomics integrated by RNA sequencing in BC. We will also discuss advances and future challenges of such radiomics-based approach.